Novo Nordisk A/S (B Shares) ADRhedged Archives

Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India

Sagar1 month ago04 mins

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The market share of India’s most popular weight‑loss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmakers flooded the market with lower‑priced copies. Eli Lilly’s Indian market share in the GLP‑1 category of…

FDA approves first GLP-1 pill for obesity from Novo Nordisk

Sagar5 months ago02 mins

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Novo Nordisk, a landmark decision that health experts say could…

Administration threatens to withhold Medicaid funding over fraud prosecutions

UK Labour leadership challenge: Starmer rivals line up

Transfer rumors, news: Man United revive interest …

Almost half strongly oppose AI data centers in their area: Gallup

what it means for China markets

Amid slump, Ohtani stars again on mound in win

Judge rules Rubio's sanction of UN rapporteur violates First Amendment

Trump-Xi meeting could test India’s positioning as China counterweight

A thank-you letter to Jason Collins, the first ope…

Trump arrives in Beijing for talks with Chinese President Xi Jinping

Novo Nordisk A/S (B Shares) ADRhedged

Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India

FDA approves first GLP-1 pill for obesity from Novo Nordisk